Related Experiment Videos
Arterial thrombosis enhanced by an acute phase response
R Jones1, M J Braam, B C Cooley
1Department of Orthopaedic Surgery, Medical College of Wisconsin, Milwaukee 53226, USA.
Annals of Plastic Surgery
|January 1, 1996
Summary
Inducing an acute phase response in rats significantly increased arterial thrombosis risk. Elevated fibrinogen levels correlated with reduced vessel patency following microvascular procedures.
Area of Science:
- Biomedical Science
- Vascular Biology
- Inflammation Research
Background:
- Acute phase response involves changes in plasma protein levels.
- Fibrinogen elevation is a common marker for trauma, inflammation, and infection.
- Elevated fibrinogen is linked to increased thrombotic risk.
Purpose of the Study:
- To investigate the impact of an induced acute phase response on arterial thrombosis.
- To assess the effect of elevated fibrinogen on microvascular procedure outcomes.
- To determine if pre-procedural inflammation increases thrombosis risk.
Main Methods:
- An acute phase response was induced in rats via subcutaneous turpentine injection.
- A bilateral femoral artery thrombosis model was created 24 hours post-induction.
- Vessel patency was evaluated at 1 and 7 days postoperatively.
- Plasma fibrinogen levels were measured before and after surgery.
Main Results:
- Rats with induced acute phase response showed significantly lower arterial patency (24%) compared to controls (56%).
- Fibrinogen levels were markedly higher in the turpentine-induced group (7.2 mg/ml) versus controls (5.4 mg/ml) 24 hours post-surgery.
- Pre-operative fibrinogen levels were also elevated in the turpentine group (5.3 mg/ml) compared to controls (2.5 mg/ml).
Conclusions:
- Pre-existing acute phase response increases the risk of arterial thrombosis after microvascular procedures.
- Elevated fibrinogen levels associated with inflammation may contribute to thrombotic complications.
- These findings highlight the importance of considering inflammatory status before vascular interventions.